Rapid Micro Biosystems Inc (NAS:RPID)

Q1 2026 Rapid Micro Biosystems, Inc Earnings Call Transcript

May 13, 2026 / 08:30 PM GMT

Release Date Price: $2.48 (-3.88%)

Transcript 10-Q8-K

Key Points

Positve

Rapid Micro Biosystems Inc (RPID) reported an 11% year-over-year revenue growth, reaching $8 million, driven by system placements and recurring revenue.
The company placed six GrowthDirect systems in the quarter, with a total of 196 systems placed globally, including 160 fully validated systems.
Product revenue increased by 36% in the first quarter, with consumables experiencing a growth of over 30%, indicating increased utilization.
Recurring revenue grew by 28%, representing 63% of total revenue, showcasing strong growth in consumables and service contract revenue.
The collaboration with Millipore Sigma is expanding opportunities for GrowthDirect placements in pharmaceutical and adjacent markets, enhancing productivity and data integrity.

Negative

First quarter gross margin was only 5%, although it showed an improvement from the previous quarter, it remains relatively low.
Service revenue decreased to $2.4 million from $3.1 million in the prior-year period, influenced by the timing of validation activities.
The company reported a net loss of $14.3 million, up from $11.3 million in the previous year, due to non-recurring G&A costs and interest expenses.
Operating expenses increased to $14.2 million from $12.1 million in Q1 2025, driven by higher R&D, sales, and marketing expenses.
Cash usage was high in Q1, with $15 million used, leaving the company with $23 million in cash, although they have a $25 million credit facility available.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

RPID.OQ - Rapid Micro Biosystems, Inc
Q1 2026 Rapid Micro Biosystems, Inc Earnings Call
May 13, 2026 / 08:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Ladies and gentlemen, please stand by. Management is having technical difficulties. Your call will begin at 4:40 p.m. Eastern Time. Once again, please stand by.

Good day, and thank you for standing by. Welcome to the Rapid MicrobioSystems First Quarter 2026 Earnings Conference Call.

At this time, all participants are in listen-only mode. After the speaker's presentation, there will be a question-and-answer session. To ask a question during the session, you will need to press *11 on your telephone. You will then hear an automated message advising your hand is raised. To withdraw your question, please press *11 again. Please be advised that today's conference is being recorded. I would now like to hand

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.